Medline (MDLN) Inventory (2024 - 2026)

Medline (MDLN) has reported Inventory for 3 consecutive years, with $4.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory changed N/A year-over-year to $4.7 billion in Q2 2026; TTM through Jun 2026 was $4.7 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $4.8 billion, up 7.02% from the prior year.
• Inventory was $4.7 billion for Q2 2026 at Medline, down from $4.8 billion in the prior quarter.
• Over five years, Inventory peaked at $4.8 billion in Q1 2026 and troughed at $4.5 billion in Q4 2024.
• A 3-year average of $4.7 billion and a median of $4.7 billion in 2025 frame the typical range for Inventory.
• The widest YoY moves for Inventory: up 7.02% in 2025, down 7.02% in 2025.
• Over 3 years, Inventory stood at $4.5 billion in 2024, then increased by 7.02% to $4.8 billion in 2025, then slipped by 2.18% to $4.7 billion in 2026.
• The last three Inventory figures came in at $4.7 billion (Q2 2026), $4.8 billion (Q1 2026), and $4.8 billion (Q4 2025), per Business Quant data.